Medication Errors and Adverse Drug Events (ADEs) in Ambulatory Pediatrics
Primary Purpose
Pediatric ALL
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Survey 1
Survey 2
Sponsored by
About this trial
This is an interventional prevention trial for Pediatric ALL
Eligibility Criteria
Inclusion Criteria: Pediatric providers at the participating office practices during the study period as well as the parents of the patients of these providers. Exclusion Criteria: Pediatric providers or patients at other office practices.
Sites / Locations
- Brigham and Women's Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Patients with prescriptions under 21
Patients who completed Survey 1
Arm Description
Pediatric visits with prescriptions. These patients parents will be given survey 1.
Patients with prescriptions under 21 whose parents complete survey 1 will be given survey 2
Outcomes
Primary Outcome Measures
Medication Errors
Secondary Outcome Measures
Adverse Drug Events
Full Information
NCT ID
NCT00229671
First Posted
September 28, 2005
Last Updated
November 22, 2019
Sponsor
Weill Medical College of Cornell University
Collaborators
Brigham and Women's Hospital, Boston Children's Hospital, The Commonwealth Fund
1. Study Identification
Unique Protocol Identification Number
NCT00229671
Brief Title
Medication Errors and Adverse Drug Events (ADEs) in Ambulatory Pediatrics
Official Title
Ambulatory Medication Errors and Adverse Drug Events (ADEs) in Pediatrics
Study Type
Interventional
2. Study Status
Record Verification Date
June 2018
Overall Recruitment Status
Completed
Study Start Date
September 2001 (Actual)
Primary Completion Date
July 2004 (Actual)
Study Completion Date
July 2005 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Weill Medical College of Cornell University
Collaborators
Brigham and Women's Hospital, Boston Children's Hospital, The Commonwealth Fund
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to determine the rates of medication errors in pediatric outpatients in 6 office practices. Further, we wish to determine the effectiveness of a computerized physician order entry (CPOE) system in reducing errors.
Detailed Description
This study has the following 2 goals:
Aim 1: To determine the rates, types, and predictors of medication errors and ADEs.
Aim 2: To perform a trial assessing the effectiveness of an intervention (CPOE) on reducing serious medication errors.
We hypothesize that:
Medication errors and ADEs are frequent in ambulatory pediatrics.
Presence of the following predictors will be associated with higher error rates: cultural, racial, socioeconomic, educational, and linguistic barriers to communication, understanding, and successful completion of prescribed therapies; complex medical or chronic medical conditions; complex medication regimens; non-physician providers with limited clinical experience; high provider workloads; and complex prescription refill systems.
Prevention strategies, including both technology-based and behavioral/ human factors-based interventions, will be effective and cost-effective in reducing rates of serious medication errors (defined as preventable ADEs and non-intercepted potential ADEs).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pediatric ALL
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
We performed a prospective cohort study of patients under age 21 from 6 office practices. Data collection methodologies included duplicate prescription review, 2 surveys, and chart review. All data were reviewed for medication errors, including those with the potential for harm (near misses) and those that actually caused harm (preventable ADEs). In addition, data were reviewed for harm from medications that were not associated with an error (nonpreventable ADEs). All ADEs were further characterized according to types and potential prevention strategies.
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
6341 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Patients with prescriptions under 21
Arm Type
Experimental
Arm Description
Pediatric visits with prescriptions. These patients parents will be given survey 1.
Arm Title
Patients who completed Survey 1
Arm Type
Experimental
Arm Description
Patients with prescriptions under 21 whose parents complete survey 1 will be given survey 2
Intervention Type
Other
Intervention Name(s)
Survey 1
Intervention Description
During the initial survey, we reviewed dispensed medications by having parents of patients with prescriptions under 21 read the medication label. We then asked questions about potential side effects, method of medication administration, communication regarding the medication with the pharmacist and the health care provider, and demographic information. Research assistants underwent several weeks of training to ensure a standardized approach to surveys.
Intervention Type
Other
Intervention Name(s)
Survey 2
Intervention Description
If the parent completed the initial survey, we attempted a second survey 2 months after the index visit to capture persistent symptoms. Surveys were translated and back translated into Spanish and Cambodian and conducted by fluent bilingual interviewers. Surveys were pretested and revised based on 2 focus groups of parents representing a broad array of socioeconomic backgrounds.
Primary Outcome Measure Information:
Title
Medication Errors
Time Frame
July 2002- August 2003
Secondary Outcome Measure Information:
Title
Adverse Drug Events
Time Frame
July 2002- August 2003
10. Eligibility
Sex
All
Minimum Age & Unit of Time
1 Day
Maximum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Pediatric providers at the participating office practices during the study period as well as the parents of the patients of these providers.
Exclusion Criteria:
Pediatric providers or patients at other office practices.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rainu Kaushal
Organizational Affiliation
Brigham and Women's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Brigham and Women's Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02120
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
No IPD will be be shared.
Learn more about this trial
Medication Errors and Adverse Drug Events (ADEs) in Ambulatory Pediatrics
We'll reach out to this number within 24 hrs